CBI
October 10 - 11, 2018 - London MA USCBI
john.kuchinski@cbinet.com
Phone:+1-339-298-2112
Once GDPR has come into effect at the end of May and the dust has cleared, what is next for life science manufacturers? Most organizations have a plan that they are executing. They have assessed the risks, taken advice and put in place procedures that address at least some of the changes. However there is likely to be ongoing adjustments required for some time after the effective date as everyone gets experience with how things will work in practice. There is no definitive understanding on how the new rules will be policed and enforced in practice by regulators. Incorporating these measures into the business and being prepared for the unknown will remain heavily with legal, compliance and information security and technology teams. CBI/UBM’s GDPR Forum for Life Sciences is a one-day summit dedicated to providing legal, compliance and IS/IT executive teams with best practices based on real-world examples, insights from data protection thought-leaders and opportunities for benchmarking across the industry.